Literature DB >> 22465357

Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice.

Josef Wanninger1, Gerhard Liebisch, Gerd Schmitz, Sabrina Bauer, Kristina Eisinger, Markus Neumeier, Noriyuki Ouchi, Kenneth Walsh, Christa Buechler.   

Abstract

Adiponectin protects from hepatic fat storage but adiponectin deficient mice (APN-/-) fed a standard chow do not develop liver steatosis. This indicates that other pathways might be activated to compensate for adiponectin deficiency. An unbiased and comprehensive screen was performed to identify hepatic alterations of lipid classes in these mice. APN-/- mice had decreased hepatic cholesteryl esters while active SREBP2 and systemic total cholesterol were not altered. Upregulation of cytochromes for bile acid synthesis suggests enhanced biliary cholesterol excretion. Analysis of 37 individual fatty acid species showed reduced stearate whereas total fatty acids were not altered. Total amount of triglycerides and phospholipids were equally abundant. A selective increase of monounsaturated phosphatidylcholine and phosphatidylethanolamine which positively correlate with hepatic and systemic triglycerides with the latter being elevated in APN-/- mice, was identified. Stearoyl-CoA desaturase 1 (SCD1) is involved in the synthesis of monounsaturated fatty acids and despite higher mRNA expression enzyme activity was not enhanced. Glucosylceramide postulated to contribute to liver damage was decreased. This study demonstrates that adiponectin deficiency is associated with hepatic changes in lipid classes in mice fed a standard chow which may protect from liver steatosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465357      PMCID: PMC3907090          DOI: 10.1016/j.yexmp.2012.03.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  42 in total

1.  High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS).

Authors:  Gerhard Liebisch; Marion Binder; Rainer Schifferer; Thomas Langmann; Berta Schulz; Gerd Schmitz
Journal:  Biochim Biophys Acta       Date:  2006-01-18

2.  Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.

Authors:  Andrea R Nawrocki; Michael W Rajala; Eva Tomas; Utpal B Pajvani; Asish K Saha; Myrna E Trumbauer; Zhen Pang; Airu S Chen; Neil B Ruderman; Howard Chen; Luciano Rossetti; Philipp E Scherer
Journal:  J Biol Chem       Date:  2005-12-02       Impact factor: 5.157

3.  Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.

Authors:  Sudha B Biddinger; Makoto Miyazaki; Jeremie Boucher; James M Ntambi; C Ronald Kahn
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.

Authors:  Toshimasa Yamauchi; Yasunori Nio; Toshiyuki Maki; Masaki Kobayashi; Takeshi Takazawa; Masato Iwabu; Miki Okada-Iwabu; Sachiko Kawamoto; Naoto Kubota; Tetsuya Kubota; Yusuke Ito; Junji Kamon; Atsushi Tsuchida; Katsuyoshi Kumagai; Hideki Kozono; Yusuke Hada; Hitomi Ogata; Kumpei Tokuyama; Masaki Tsunoda; Tomohiro Ide; Kouji Murakami; Motoharu Awazawa; Iseki Takamoto; Philippe Froguel; Kazuo Hara; Kazuyuki Tobe; Ryozo Nagai; Kohjiro Ueki; Takashi Kadowaki
Journal:  Nat Med       Date:  2007-02-01       Impact factor: 53.440

5.  Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.

Authors:  Thomas A Bell; J Mark Brown; Mark J Graham; Kristina M Lemonidis; Rosanne M Crooke; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-04       Impact factor: 8.311

Review 6.  Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Büchler
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-06

7.  High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes.

Authors:  Markus Neumeier; Alexander Sigruener; Elke Eggenhofer; Johanna Weigert; Thomas S Weiss; Andreas Schaeffler; Hans J Schlitt; Charalampos Aslanidis; Pompiliu Piso; Thomas Langmann; Gerd Schmitz; Jürgen Schölmerich; Christa Buechler
Journal:  Biochem Biophys Res Commun       Date:  2006-11-20       Impact factor: 3.575

Review 8.  The epidemiology of nonalcoholic fatty liver disease in adults.

Authors:  Jeanne M Clark
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

Review 9.  The fate and intermediary metabolism of stearic acid.

Authors:  Harini Sampath; James M Ntambi
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

10.  Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.

Authors:  Hiroyuki Oku; Fumihiko Matsuura; Masahiro Koseki; Jose C Sandoval; Miyako Yuasa-Kawase; Kazumi Tsubakio-Yamamoto; Daisaku Masuda; Norikazu Maeda; Tohru Ohama; Masato Ishigami; Makoto Nishida; Ken-ichi Hirano; Shinji Kihara; Masatsugu Hori; Iichiro Shimomura; Shizuya Yamashita
Journal:  FEBS Lett       Date:  2007-09-29       Impact factor: 4.124

View more
  2 in total

1.  Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytes.

Authors:  Josef Wanninger; Gerhard Liebisch; Kristina Eisinger; Markus Neumeier; Charalampos Aslanidis; Lisa Voggenreiter; Rebekka Pohl; Thomas S Weiss; Sabrina Krautbauer; Christa Buechler
Journal:  Metabolites       Date:  2014-05-23

2.  Developmental programming by maternal insulin resistance: hyperinsulinemia, glucose intolerance, and dysregulated lipid metabolism in male offspring of insulin-resistant mice.

Authors:  Elvira Isganaitis; Melissa Woo; Huijuan Ma; Michael Chen; Wen Kong; Aristides Lytras; Vicencia Sales; Jennifer Decoste-Lopez; Kyung-Ju Lee; Cianna Leatherwood; Deborah Lee; Connor Fitzpatrick; Walter Gall; Steven Watkins; Mary-Elizabeth Patti
Journal:  Diabetes       Date:  2013-11-01       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.